Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Utah Medical v. Tyco

This article was originally published in The Gray Sheet

Executive Summary

Utah Medical plans to seek an injunction against further sales of Tyco/Kendall-LTP's Softrans 4000 intrauterine pressure catheter following a $20 mil. jury damages award to Utah Medical in a 1997 patent suit in Utah federal court on Jan. 16. The court found the device infringes Utah patent 4,785,822 for a "disposable intracompartmental pressure transducer" relating to Utah's Intran Plus...

You may also be interested in...



Utah Medical v. Tyco

Permanent injunction against sales of Tyco/Kendall-LTP's Softrans 4000 intrauterine pressure catheter is issued by Utah federal court, along with $23 mil. in damages and interest to Utah Medical, following a January jury verdict that Tyco infringed a patent related to Utah's Intran Plus IUPC (1"The Gray Sheet" Jan. 21, 2002, In Brief). Utah, which filed suit in 1997, maintains that Tyco group purchasing contracts with Premier and Novation kept the Intran Plus from 70% of the hospital market...

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel